DOW

chief66 wrote: Heading very close to 22770

If it closes below 23300 would it correct to assume a bearish signal down possibly to 21000?,

Looks like a H&S to coincide, with TF’s support line.

longterm_view wrote:

chief66 wrote: Heading very close to 22770

If it closes below 23300 would it correct to assume a bearish signal down possibly to 21000?,

Looks like a H&S to coincide, with TF’s support line.

I'll hold on for now....

Massive Spike some +700 points on the Dow after the close.

markets like death and disease. who would have thunk it!

Yep....gone crazy.....I had to close my shorts for a big loss....then reversed to long.....
It looks like it’s heading towards the 61.8 fib....I will look to short at that level now...and not before..,
Serious strength in the markets.......

remo wrote: Yep....gone crazy.....I had to close my shorts for a big loss....then reversed to long.....
It looks like it’s heading towards the 61.8 fib....I will look to short at that level now...and not before..,
Serious strength in the markets.......

24300 was a beauty, but you're right, this one goes to 25200 (which is 61.8 by my reckoning - happy to be corrected).

And yep Remo, it is brutal - losses are so damned hard to take - it's like pushing a rock up a mountain trying to get the cash back.

But, I'm not sure there's serious strength - i don't know that much to be fair, but this move up wasn't built on any strong foundation (apart from the Fed maybe!)

dow - daily.
uk.advfn.com/p.php?pid=chartscreenshotsh...f4RH62QaRQAlZvXZ8%3D

That's the Dow for us!! just when you think a decent drop will happen....
up it goes....and if it gaps up above this wedge for what will be a second higher high then it really is bye bye to the bears imvho...

Looks like trumps is starting to open up the lockdown already!
i thought they were a few weeks behind us?!?

if the markets start seeing that the worst of this is over and we are past the peak...then the upside could well be strong here....we may even make new highs in a week or two!!
bonkers

atb, wdik, dyor,
trendfriend

Shares of Gilead Sciences Inc soared 15% on Thursday after a media report suggested that severe COVID-19 patients were positively responding to the drugmaker's experimental treatment remdesivir.
A Chicago hospital treating COVID-19 patients with the antiviral medication as part of a trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, according to medical news website STAT

This is the reason markets jumped so much...